The USPTO has issued Neovasc (NASDAQ:NVCN), Patent No. 10,433,952, titled: “PROSTHETIC VALVE FOR AVOIDING OBSTRUCTION OF OUTFLOW”.
The granted claims are directed to a prosthetic
valve that helps reduce LVOT obstruction and improve unobstructed blood
flow through the Tiara and the native ventricle.
Shares are up 14% premarket.
https://seekingalpha.com/news/3505712-neovasc-nabs-new-patent-u-s-shares-14-percent-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.